I have a couple of things in no particular order. I think it's heartening that you seem to be getting to the bottom of some of big pharma's issues, or the pharmaceutical industries' issues with their processes. As I say, it's a black box to me, and I've tried to open that unsuccessfully.
I would take a slightly different view. Everyone at the moment is talking about team-based care and collaborative approaches for physicians and health care providers. I really think that what I'm seeing here is an example of the pot calling the kettle black. Really and honestly, you guys need to have a collaborative approach to health care. You can't just hive off a bit based on one interpretation of a piece of legislation that's 170 years old or more. You can try, but it really is not an edifying spectacle for the patients who don't have their medications. The bottom line, from the patient's point of view, is that drugs are not like gas, for example. Just imagine what would happen if we had rotating random shortages of gasoline in communities and how the response may differ from random rotating shortages of drugs. Drugs are different. Drugs have become an essential part of chronic disease management and acute disease management in a way that nobody ever envisaged when medicare was set up.